海泰新光收盘上涨5.83%，滚动市盈率41.55倍，总市值59.66亿元

Company Overview - Qindao Haitai Newlight Technology Co., Ltd. specializes in the research, manufacturing, sales, and service of medical endoscope instruments and optical products [1] - The main products include 4K fluorescence/white light laparoscopes, endoscope light source modules, camera adapters, and lenses [1] Financial Performance - For Q1 2025, the company reported revenue of 147 million yuan, a year-on-year increase of 24.86% [1] - The net profit for the same period was 46.69 million yuan, reflecting a year-on-year growth of 21.45% [1] - The gross profit margin stood at 64.98% [1] Market Position - As of August 12, the closing price of the stock was 49.77 yuan, with a 5.83% increase, resulting in a rolling price-to-earnings (PE) ratio of 41.55, the lowest in 331 days [1] - The total market capitalization is 5.966 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 57.51, with a median of 41.25, placing Haitai Newlight at the 78th position in the industry ranking [1][2] Institutional Holdings - As of Q1 2025, there are 9 institutions holding shares in Haitai Newlight, all of which are funds, with a total holding of 10.4214 million shares valued at 407 million yuan [1]